LIK

LIMES Schlosskliniken AG

Stock XETRA – Stock Market Prices, News & Analysis

Entreprise allemande opérant dans le secteur de la santé, spécialisée dans la gestion et l’exploitation d'hôpitaux privés et cliniques spécialisées.

€ 480.00
1.69 %

LIMES Schlosskliniken AG

480.00
1.69 %
LIK

Entreprise allemande opérant dans le secteur de la santé, spécialisée dans la gestion et l’exploitation d'hôpitaux privés et cliniques spécialisées.

Price history of LIMES Schlosskliniken AG
Price history of LIMES Schlosskliniken AG

Performance & Momentum

6 Months 27.72 %
1 Year 66.67 %
3 Years 44.17 %
5 Years

Strategic Analysis

LIMES Schlosskliniken AG • 2026

LIMES Schlosskliniken AG is positioned as a key player in the management of private hospitals and specialized clinics in Germany, leveraging a model centered on operational efficiency and quality of care. Its focus on targeted medical services enables it to stand out in a sector with sustained growth, particularly favorable to private healthcare.

Strengths
  • Recognized expertise in managing specialized hospital facilities
  • Positioning in the German market, a dynamic healthcare sector with strong demand for specialized care
  • Very favorable long-term shareholding performance track record
Weaknesses
  • Dependence on the German market, limiting geographic diversification
  • Highly regulated sector with constraints that can affect profitability
Momentum

Strong momentum reflects growing investor interest, supported by a notable improvement in valuation over various periods. The absence of recent news suggests operational stability, which may enhance the appeal of an investment strategy focused on resilience and medium-term growth.

Similar stocks to LIMES Schlosskliniken AG

Was this page helpful?

Your feedback helps us improve our research.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases
Anantys Invest on iPhone